Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07171281Recruiting
Timing meals to improve blood sugar and heart health
This study tests whether eating at specific times of day can help control blood sugar and improve heart health in people with prediabetes or type 2 diabetes. It compares two different eating schedules to see which works better.
NuthetalAges 18–75 - NCT07175909Recruiting
Tear analysis for dry eye diagnosis and management
This study looks at proteins in your tears to better understand and treat dry eye disease. You may qualify if you have dry eye symptoms and certain test results show your eyes are not functioning normally.
Hong KongAges 18–65 - NCT07177417RecruitingPhase 4
How the immune system responds to FluMist in the airways
This study tests how the immune system in your nose and airways responds to the FluMist nasal spray flu vaccine. It may help doctors understand why some people get better protection from the flu.
St Louis, MissouriAges 18–40 - NCT07178353Recruiting
How bedrest affects leg muscles in young adults
This study looks at how 5 days of complete bedrest changes the leg muscles of healthy young adults. It may help researchers understand muscle loss and how to prevent it.
Kingston, OntarioAges 18–30 - NCT07181564Recruiting
Anesthesia methods and safety in sinus surgery
This trial compares different anesthesia techniques during functional endoscopic sinus surgery to see which one protects the brain best and improves the surgical field. It may help patients understand the safest approach for their procedure.
Pátrai, AchaiaAges 18–90 - NCT07187401RecruitingPhase 1/Phase 2
Study of a new RNA drug for PNH anemia
This trial tests an experimental RNA drug (ALN-CFB) for people with PNH who still have low red blood cell counts despite taking a C5 inhibitor. The drug aims to block a protein (complement factor B) to improve anemia.
Toronto, OntarioAges 18 years+ - NCT07187531RecruitingPhase 2
Testing a new drug to slow type 1 diabetes progression
This trial tests an experimental drug called SAB-142 to see if it can slow down or stop the progression of type 1 diabetes. It is designed for people who were recently diagnosed and still produce some insulin on their own.
San Francisco, CaliforniaAges 5–40 - NCT07189715Recruiting
Testing a new memory technique for anxiety
This trial tests a technique called imagery rescripting, which helps change how you remember upsetting memories from childhood. A computer program may help make this more effective. This could help people with high anxiety who remember their parents being critical.
Poznan, WielkopolskaAges 18–35 - NCT07203599RecruitingPhase 1/Phase 2
Stem cell exosomes for male pattern baldness
This trial tests a treatment made from umbilical cord stem cell exosomes for young men with male pattern baldness. It aims to see if this natural substance can help regrow hair.
Shenzhen, GuangdongAges 18–35 - NCT07205926RecruitingPhase 1
Testing a new Shigella vaccine in healthy adults
This trial tests a new Shigella vaccine in healthy adults to see if it is safe and creates a good immune response. It is a first-in-human study, meaning this is the first time the vaccine is given to people.
Cincinnati, OhioAges 18–49 - NCT07207044Recruiting
Fasting and exercise to slow aging
This trial tests whether a specific schedule of fasting (time-restricted eating) combined with exercise can help slow aging. You will follow a daily eating window and perform prescribed physical activity to see how it affects your health.
Copenhagen, Copenhagen NAges 20 years+ - NCT07209189RecruitingPhase 2
Chemo and immunotherapy before surgery for head and neck cancer
This trial tests a combination of chemotherapy and an immunotherapy drug called Toripalimab before surgery for certain head and neck cancers. The goal is to see if this approach can reduce the extent of treatment needed while still being effective.
Baltimore, MarylandAges 18 years+ - NCT07210359Recruiting
New treatment for immature teeth
This trial tests a regenerative treatment for immature permanent teeth (front teeth with developing roots) in children and teens. The goal is to help the tooth's pulp heal and allow the root to continue growing naturally.
Kafr ash Shaykh, Kafr ElsheikhAges 9–15 - NCT07214662RecruitingPhase 1
Study of GDC-0587 with or without giredestrant for advanced breast cancer
This trial tests a new drug (GDC-0587) by itself or with another drug (giredestrant) in people with a type of breast cancer that is ER-positive and HER2-negative, and has spread or cannot be removed. It aims to see if the drug is safe and works against the cancer.
Grand Rapids, MichiganAges 18 years+ - NCT07215923RecruitingPhase 1
Study of ATI-1013 in healthy smokers who want to quit
This trial tests a new drug called ATI-1013 in healthy smokers. It aims to see how safe the drug is and how it works in the body. If you smoke at least 10 cigarettes a day and are in good health, you might be able to join.
Overland Park, KansasAges 23–59 - NCT07216066RecruitingPhase 1
Study of ALN-SNCA for early Parkinson's disease
This trial tests a new experimental drug called ALN-SNCA, given as an injection into the spinal fluid, for people with early Parkinson's disease. The goal is to see if it is safe and well-tolerated.
Montreal, QuebecAges 50–80 - NCT07216781RecruitingPhase 1
Klotho gene therapy safety trial
This trial tests a new gene therapy that uses a harmless piece of DNA (called a plasmid) to help your body make more Klotho, a protein linked to healthy aging. The goal is to see if it's safe and whether it might slow aging or improve health.
Austin, TexasAges 23–90 - NCT07217652Recruiting
Brain study on mental flexibility
This study uses MRI scans to understand how a part of the brain called the mediodorsal thalamus helps you switch between tasks and adapt to new situations. It aims to learn more about cognitive flexibility in healthy adults.
Iowa City, IowaAges 18–35 - NCT07219368RecruitingPhase 1
Testing a new drug (MT-201) safety in healthy adults
This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.
San Diego, CaliforniaAges 19–55 - NCT07221123RecruitingPhase 2
Smell and memory training for brain health
This study tests whether smell exercises can improve memory and thinking in people who are worried about their brain health. If you are 40 or older and have mild memory concerns, you may be able to join.
Birmingham, AlabamaAges 40 years+ - NCT07222215RecruitingPhase 2
Capacitabine with or without elacestrant for ER+ breast cancer
This trial tests if adding a new oral targeted therapy (elacestrant) to standard chemotherapy (capecitabine) works better than chemotherapy alone for people with a specific type of advanced breast cancer that is hormone-sensitive (ER-positive) and has stopped responding to hormone therapy.
Boston, MassachusettsAges 18 years+ - NCT07233213RecruitingPhase 3
IVIG for chronic low platelet condition
This trial tests an intravenous immunoglobulin (IVIG) treatment for chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, causing low counts and bleeding risk. It aims to safely raise platelet levels using donated antibodies.
Ankara, AltındağAges 18–65 - NCT07234773RecruitingPhase 1
Study of a new injectable drug for rheumatoid arthritis
This early-stage study tests a new injectable medicine (KT501) for people with moderate to severe rheumatoid arthritis who have not responded well enough to other treatments and have specific antibodies in their blood. It aims to see how safe and well-tolerated the drug is.
BayswaterAges 18–75 - NCT07236905Recruiting
HIV testing access for young children in Uganda
This study makes it easier for children in Uganda to get tested for HIV. It helps find kids who haven't been tested recently so they can learn their status and get care if needed.
MbararaAges 1.5 years–5 years
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,241 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.